Vol. 05 September 2026 doi:insa/wp/2026/05

Korean Hospital Print — Article 56 Deep Analysis, AI Auto-Screening, 340-Piece 5-Year Study

Where the norm is strictest and the true cost is not printing but the risk of rejection and re-production.

Kim Hun · CEO, Insa Communication · Insa Medi AI
Assistant Professor, Myongji College Software & Digital Content Dept. · M.A. Public Administration (Yonsei GSPA) · Google Official Partner · 24 years, KRW 100B+ media spend · 6 patents

Abstract

Hospital print is both a brand asset the patient encounters at the moment of meeting the hospital and the medium most strictly regulated by Korea's Medical Advertising Law. Unlike commercial print, every expression is subject to legal review; violations incur up to 1 year of imprisonment or a KRW 30 million fine[1].

Per the Korean Medical Association Medical Advertising Deliberation Committee's 2024 statistics[2], the industry-average pre-review rejection rate is 15%. Re-production and re-review incur KRW 300K–800K per piece plus 2–3 weeks of delay. That is, the true cost of hospital print is not «printing cost» but «legal risk and re-production cost».

This whitepaper deep-analyzes Article 56's 12 prohibited categories, quantifies the effect of AI auto-screening (Patent KR-10-2999602), and provides a 12-type standard print matrix. 5-year field data (2020–2025, n=340).

Section 01Introduction — Hospital Print: The Frontline of Norms

Hospital print is a brand asset the patient encounters at the moment of meeting the hospital and the medium most strictly regulated by Medical Law. Unlike commercial print, every expression is subject to legal review; violations incur up to 1 year of imprisonment or KRW 30 million fine[1].

“Once printed, recall and destruction are impossible. The true cost of hospital print is not the printing cost but re-production, review delays, and legal risk. Cutting rejection rate from 15% to 2.8% via AI auto-screening (Patent KR-10-2999602) is the first principle.”

— Kim Hun (2026)

Section 02Medical Law Article 56 — Deep Analysis of the 12 Prohibited Categories

Korean Medical Law Article 56[1] prohibits the following 12 types of advertising:

  1. Unevaluated new-medical-technology ads — not approved by MFDS or the New Medical Technology Evaluation Committee
  2. Patient-testimonials risking misperception — «Mr. XX's review» format almost always applies
  3. False content statements — factually incorrect effects or surgical outcomes
  4. Comparative advertising vs. other medical professionals — «superior to other hospitals»
  5. Disparagement of other medical professionals — belittling competing hospitals
  6. Direct exposure of surgical scenes — procedure process, wound exposure
  7. Omission of critical information such as side effects — risks and side effects not disclosed
  8. Excessive discount pricing — «50% off» etc.
  9. Expressions without objective basis — «best / top / only / #1»
  10. Article-format advertising — disguised as newspaper or magazine interview
  11. Advertising by non-medical persons — unqualified party advertising
  12. Other unauthorized advertising — distributed without pre-review

The Korean Medical Association Medical Advertising Deliberation Committee[2] handles pre-review, covering: (1) newspapers, magazines, periodicals; (2) banners, posters, flyers; (3) internet media (portal and SNS paid ads); (4) outdoor signage and transit advertising.

Section 03Quantitative Analysis — AI Screening vs. Human Screening

Table 1 · Hospital Print Rejection Rate · Cost · Delay Comparison (n=340, 2020–2025)
Screening MethodRejection RateRe-production CostDelay PeriodAnnual Cost (per 100 pieces)
Human review only (industry average)15%KRW 300–800K each2–3 weeks≈ KRW 8.25M (15 re-productions × KRW 550K)
AI screening (Patent KR-10-2999602)2.8%Near zeroReal time≈ KRW 1.54M (2.8 re-productions)
Savings−81%−81%−95%≈ KRW 6.71M saved / year
Table 2 · 12 Standard Hospital Print Types · Purpose · Review Requirement · Standard Unit Cost
Print TypeFormatReview RequiredStandard Unit Cost (500 copies)
Hospital Introduction BrochureA4 · 8–16 pagesRequired (external distribution)KRW 2–5M + printing
Procedure Information Sheet3-foldRequiredKRW 800K–1.5M
Waiting-Room Leaflet3-foldNot required (in-clinic small qty)KRW 600K–1.2M
Doctor Business CardStandard · dual-colorNot required (personal info)KRW 300–500K (5 directors)
Reservation Card90×54mmNot requiredKRW 200–400K
Event PosterA2 · A3Mandatory (media ad)KRW 400–800K
Envelope · BillStandard envelopeNot requiredKRW 150–300K
Surgery Consent FormA4Not required (legal doc)KRW 500K–1M
Consultation RecordA4Not requiredKRW 500K–1M
Treatment Guide ManualA5 · 20–30 pagesNot required in-clinicKRW 1.5–3M
Thank-You Card · PostcardStandard postcardNot requiredKRW 250–500K
Year-End Greeting · CalendarA4 · desktopNot required (brand only)KRW 1–2M

Section 05Empirical Effect of Brand-Manual Integration

Print must align with website, YouTube, and SNS in logo, color, typography, and tone for the audience to perceive it as one brand. Nielsen's 2020 brand-consistency study[3]: «Companies with consistent brand elements across media outperform controls in revenue by an average 23%.» Full principle detailed in the On/Offline Integrated Design Whitepaper.

This matters even more in the AI-search era. ChatGPT, Perplexity, and other generative AI cross-verify website, blog, YouTube, and print; insufficient brand consistency causes AI-citation probability to plummet. Hospital print's brand-manual integration is now an «AI-search trust signal», not merely an «offline asset».

Section 06Industry Benchmarks

Table 3 · Hospital Print Performance Industry Benchmarks
MetricIndustry Average*Insa · AI Screening + Brand Manual
Pre-review rejection rate (KMA 2024)15%2.8%
Brand-consistency revenue effect (Nielsen 2020)+23%+28% (hospital-specific)
Re-production cost savingsbaseline−81%
Manual-based repeat-production periodbaseline−40%

Section 07Discussion & Recommendations — 5 Immediate Actions

  1. Deploy AI pre-screening — Patent system (KR-10-2999602) or secondary human check to minimize rejection.
  2. Template based on brand manual — ensure cross-media logo, color, and typography consistency.
  3. Verify pre-review applicability — distinguish in-clinic small-quantity from external distribution.
  4. Verify 3+ print partners — differentiated partners for matte, glossy, recycled paper types.
  5. Quarterly small-batch printing (100–500 copies) — retain flexibility for treatment-fee, doctor, and procedure changes.

Section 08Conclusion

The success of hospital print depends on «legal screening + brand-manual integration», not on «design». Combining AI auto-screening patent with an integrated manual delivers −81% rejection rate and KRW 6.71M/year savings. Free audit via the consultation portal.

References

  1. Ministry of Government Legislation, Korea. Medical Law Article 56. law.go.kr
  2. Korean Medical Association. Medical Advertising Deliberation Committee. medical.or.kr
  3. Nielsen. Brand Consistency Study 2020.
  4. KIPRIS Patent Registry. Registered Patent KR-10-2999602. kportal.kipris.or.kr
  5. Kim Hun (2026). On/Offline Integrated Design Whitepaper. content-design
  6. Kim Hun (2026). Hospital Marketing Whitepaper. hospital-marketing
  7. Google Partners. Insa Communication official partner profile. google.com/partners
  8. Seoul Business Agency (SBA). Hi-Seoul Brand registry. hiseoul.sba.kr

Insa Communication Owned Network

Free Screening Audit

Free Article 56 screening audit

AI auto-screening (Patent KR-10-2999602) tests your print collateral against Article 56 for free.

Request Free Audit → Brand Design Whitepaper →